Provider
QP11-23 Commercial Pharmacy Benefit Exclusion for Cimzia®
Program effective Date: Feb 22, 2023
Documents & Forms Results
Displaying 901 - 910 of 3636 results
Provider
QP12-23 Change in Prior Authorization Process for Experimental or Investigative Services
Program effective Date: Feb 22, 2023
Provider
QP6-23 Commercial Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Rebyota™, and Sunlenca® Injection
Program effective Date: Feb 08, 2023
Provider
QP7-23 MHCP Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Lunsumio™, Rebyota™, Sunlenca® Injection, and Vivimusta
Program effective Date: Feb 08, 2023
Provider
QP8-23 Commercial Formulary Addition for Growth Hormone Therapeutic Class: Genotropin® (somatropin)
Program effective Date: Feb 08, 2023
Provider
QP9-23 Commercial Pharmacy Benefit Exclusion for Select Medications
Program effective Date: Feb 08, 2023
Provider
P77R1-22 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective January 30, 2023
Program effective Date: Feb 01, 2023